CLASS II Drug recall · Reported 24 Aug 2022 · FDA Enforcement Report

Acetaminophen Injection, 10 mg/mL recalled by Baxter Healthcare

Baxter Healthcare is recalling Acetaminophen Injection, 10 mg/mL, 1,000 mg/ Viaflo container, Single Dose Container, For, distributed nationwide in the US. The recall was initiated on 4 Aug 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots: 20K19G64T1, Exp 10/31/2022; 21K23G65, 21K25G65, 21K26G65, 21K29G67, Exp 10/31/2023; 21L10G65, 21L13G66, 21L14G66, 21L15G65, Exp 11/30/2023
NDC36000-306, 36000-372
Quantity recalled85,680 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1348-2022
FDA event ID
90699
Recalling firm
Baxter Healthcare, Deerfield, IL
Manufacturer
Baxter Healthcare Corporation
Classification
Class II
Status
Terminated
Recall initiated
4 Aug 2022
FDA classified
16 Aug 2022
Reported
24 Aug 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Temperature Abuse
Drug class
Pain Medication

Timeline

4 Aug 2022Recall initiated by company
16 Aug 2022Classified by FDA+12 days
24 Aug 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Temperature Abuse: Product distributed in refrigerated trucks with labels attached to pallets indicating "Refrigerate Upon Arrival", however product is labeled to be stored in a controlled room temperature environment.

Foods that need refrigeration and were stored or shipped too warm can grow harmful bacteria without any change in look or smell.

Product as listed by the FDA

Acetaminophen Injection, 10 mg/mL, 1,000 mg/100 mL, 100 mL VIAFLO container bag, Single Dose Container, For Intravenous Use Only, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA; NDC 36000-306-60

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Temperature Abuse: Product distributed in refrigerated trucks with labels attached to pallets indicating "Refrigerate Upon Arrival", however product is labeled to be stored in a controlled room temperature environment.

Which lots are affected?

Lots: 20K19G64T1, Exp 10/31/2022; 21K23G65, 21K25G65, 21K26G65, 21K29G67, Exp 10/31/2023; 21L10G65, 21L13G66, 21L14G66, 21L15G65, Exp 11/30/2023

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Baxter Healthcare

All 578

Other Acetaminophen recalls

All 58